Abstract

Subject. The article presents an investigation of the dental status of patients with early manifestations of tooth wear. The effectiveness of applying a new pharmacologically active composition of nanostructured fluorine hydroxyapatite as a remineralizing agent in the form of a gel in comparison with traditional methods was evaluated. Objectives. To study the effectiveness of a new pharmacologically active composition of nanostructured fluorhydroxyapatite application in the treatment of early manifestations of tooth wear. Methods. 153 patients were examined at the stages of remineralizing therapy with using a new pharmacologically active composition and traditional methods, indexed OHI-S, PMA, KPU, periodontal index, indicators of electrometry, test of enamel resistance, quality of life. Results. Within 1 year of observations in the study groups, in 91.2% cases, a persistent remission of the disease without progression of the loss of hard dental tissues was observed against the background of a decrease in the electrometry and test of enamel resistance test. 56.4% of patients throughout the year noted the absence of a symptom of hyperesthesia. The recurrence of the symptom of hyperesthesia against a background of fixed indices of resistance and electrical conductivity of enamel was noted by 34.8% of patients. In 8,8% of cases there was a lack of dynamics of indices and reduction of hyperesthesia. Conclusions. The level of caries-resistance and electrical conductivity of enamel of the teeth of patients of two groups was studied: with facets of erasability within the enamel and with dotted dentin damage against the background of the course of remineralizing therapy with using pharmacologically active composition of nanostructured fluorine hydroxyapatite. The relationship between the reduction of the symptom of hyperesthesia and the increase in the level of dental health of patients after the end of treatment was revealed.

Highlights

  • Subject. The article presents an investigation of the dental status of patients

  • 153 patients were examined at the stages of remineralizing therapy

  • a persistent remission of the disease without progression of the loss of hard dental tissues was observed against the background of a decrease

Read more

Summary

Introduction

Цель исследования — изучение эффективности применения новой фармакологически активной композиции наноструктурированного фторгидроксиапатита при лечении ранних проявлений повышенной стираемости зубов. Группа исследования (26 человек) получали лечение в виде однократного покрытия поверхности зубов фармакологически активной композицией нФАП в течение 5 минут с повторным нанесением через 1 месяц. Группа исследования (30 человек) получали лечение в виде однократного покрытия поверхности зубов фармакологически активной композицией НФАП в течение 5 минут с последующим покрытием герметиком ClinPro Varnish XT (3M).

Objectives
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.